Dr. Luigi Nezi @ istituto europeo di oncologica in Milan / Whirlwind intro to #microbiota / Brilliant work! / Fondazione NIBIT #ThinkTank - slides coming very fast #cancer #immunotherapy Jennifer Wargo MD carlobifulco #finishcancer #microbiome

Excited to share our Cancer Cell review on #AI-driven multimodal data integration in #oncology. We discuss methods, and app. of multimodal data fusion, interconnection, assoc. disc. & more. Brigham and Women's Pathology MGH Pathology🔬 Harvard Data Science Initiative Broad Institute Link: bit.ly/3Cshmhc 1/2

“The joy of not feeling like every month is going to take away something from me is an incredibly freeing thing," says Tom, a retired surgeon battling #ProstateCancer. Read about Tom's incredible story here: ccr.cancer.gov/news/article/f…. #Immunotherapy #ClinicalTrial @gulleyj1

Towards drugging the undraggable in cancer: progress is being made vs KRAS, mutated in 1/4 cancers, but we're not there yet for its most common mutation (G12D) nature.com/articles/d4158… feature nature by Heidi Ledford

Another huge win for Neoadjuvant immunotherapy: relatlimab + nivolumab in melanoma. The combo resulted in pCR=57%; OPR=70%. Any path response correlated w 1 & 2 yr RFS of 100% & 92%, compared to 88% & 55% for those without (P = 0.005). ⁦Nature Medicine nature.com/articles/s4158…

linkedin.com/pulse/genome-e…

At #ASHG22 tomorrow: first results from the Providence #Geno4ME clinical whole genome study presented by our senior scientist Josiah Wagner (11am, population health track).

Great to be back in person at #AMP22! We are presenting a whopping six abstracts this year... big thanks to our amazing team members and collaborators! Abstracts: G069. Design and Validation of a Whole-Genome Sequencing-Based Assay for Population Health. John Welle et al.

PieningLab Alexa 💥At #AMP22 ? checkout what PieningLab Gurus & collaborators carlobifulco Rom Leidner Walter J Urba MD, PhD Dr Eric Tran & more Chiles Research Institute Providence Oregon Providence Illumina are doing to accelerate #research, improve how #patients are treated & #FinishCancer Rod Hochman M.D. #Genomics

💥 GREAT START TO FRIDAY! Dr Brian Piening of PieningLab Chiles Research Institute Providence Oregon is presenting @ EACRI Lab Mtg on “Multi-Omic Interrogation of the #Tumor #Immune Micro Environment” using latest tech #FinishCancer Illumina NanoString Lunaphore (a Bio-Techne brand) /Thanks Murdock Trust

This is going to be an excellent meeting!

Last chance to register: #spatialbiology #progresshappenstogether #singapore A*STAR Research A*STAR

Back at ASCO, check out the Illumina abstracts. illumina.com/company/news-c…

Happy to present at #ASCO23 this afternoon the first outcomes from our ongoing study evaluating large-scale implementation of reflex tumor comprehensive genomic profiling (ProvSeq 523) at Providence. Key collaborators Illumina, Microsoft. #FINISHCANCER meetings.asco.org/abstracts-pres…

Fully Automated Sequential Immunofluorescence (seqIF) for Hyperplex Spatial Proteomics biorxiv.org/content/10.110…

FDA Approves 1st Cellular Therapy to Treat Patients w Metastatic Melanoma. Testament to the vision of Dr. Steven Rosenberg & many Surgery Branch who stood on his shoulders, including our own Dr. Brendan Curti Bernard A Fox Walter J Urba MD, PhD & Eric Tran Chiles Research Institute fda.gov/news-events/pr…

Discover how multi-omics is revolutionizing disease biology! Join the 2024 Multi-omics Meeting Dec. 1–3 in QLD, Australia and view the latest in and omics-based tissue and liquid biopsy profiling. Abstract submissions due Aug. 2. Learn more: ow.ly/2nWs50SCpB7 carlobifulco

Don't miss the 2024 Multi-omics Meeting Dec. 1–3 in QLD, Australia! Engage with global researchers and understand digital pathology and omics-based deep tissue profiling. View agenda and register now: ow.ly/Su4650SCqac carlobifulco Joe Yeong Tullia Bruno, PhD